Platinum Investment Management LTD Bio Atla, Inc. Transaction History

Platinum Investment Management LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$2.13 - $5.38 $194,388 - $490,989	-91,262 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$19.0 - $30.95 $657,780 - $1.07 Million	34,620 Added 61.12%	91,262 $1.79 Million
Q3 2021 Nov 09, 2021	BUY	$29.44 - $43.74 $675,265 - $1 Million	22,937 Added 68.05%	56,642 $1.67 Million
Q1 2021 May 13, 2021	SELL	$32.41 - $70.91 $1.18 Million - $2.57 Million	-36,295 Reduced 51.85%	33,705 $1.71 Million
Q4 2020 Feb 12, 2021	BUY	$31.02 - $35.16 $2.17 Million - $2.46 Million	70,000 New	70,000 $2.38 Million

17.4M

500

33.5K

Ticker BCAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,304,100
Market Cap $25M
Description
BioAtla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for soft tissue and bone sarcoma tumors, non-small cell lung cancer (NSCLC), and ...

Get notified when there are updates to the investment portfolio of Platinum Investment Management LTD, based on Form 13F filings with the SEC.

Stay updated on Platinum Investment Management LTD with notifications on news.